ABSTRACT
Objectives To measure changes in cause of death dynamics in 2019 and 2020 and the relationship between concurrent occurrence of the COVID-19 pandemic and mortality outcome by race and ethnicity.
Patients and Methods We used resident mortality data from the Minnesota Department of Health (MDH) to conduct retrospective statistical analysis of deaths in Minnesota in 2019 relative to 2020 to assess changes in mortality in a pre-pandemic and pandemic period.
Results COVID-19 strongly contributed to ethnicity-related mortality disparities in Minnesota. Not only was there a greater proportion of COVID-19 decedents within the Black and Hispanic populations, but their average decedent age was markedly lower relative to the White population. The Black population experienced a disproportionate increase in decedents with a 34% increase during 2020 compared to 2019.
Conclusions This retrospective analysis of death dynamics and mortality outcomes in Minnesota from 2019 to 2020 demonstrated an increase in adverse mortality outcomes relative to the pre-pandemic period that disproportionately impacted Black and Hispanic minority populations. Access to non-pharmaceutical interventions combating COVID-19 infection in Black and Hispanic communities should be expanded in Minnesota.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by University of Minnesota grant #P01AG005842
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB of University of Minnesota Twin Cities waived ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵* Footnote: This manuscript is dedicated to the memory of Jonathan I. Ravdin, scholar, mentor, physician-scientist and friend.
Concept and Design: Blake, Ravdin, Marka
Acquisition, Analysis, and Interpretation of Data: Blake, Ravdin, Marka
Drafting of the Manuscript: Blake, Marka, Steer
Review and Revisions of the Manuscript: Blake, Marka, Steer
Statistical Analysis: Blake, Marka
Obtained Funding: Ravdin
Administrative, Technical, and Material Support: Blake
Supervision: Ravdin, Steer
Conflict of Interest Disclosures: No disclosures were reported by the co-authors.
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
ABBREVIATIONS
- COVID-19
- coronavirus disease of 2019;
- ARDS
- acute respiratory distress syndrome
